Difference between revisions of "CCSP - 2021"

From MGH Learn Pathology
Line 31: Line 31:
 
* Cutaneous Lymphoma - Dr. Duncan
 
* Cutaneous Lymphoma - Dr. Duncan
 
* Pitfalls in Dx Myelodysplastic - Dr. Hasserjian
 
* Pitfalls in Dx Myelodysplastic - Dr. Hasserjian
 +
<br>
 
{{ColorText|Tuesday, November 2, 2021|||3|}}<br>
 
{{ColorText|Tuesday, November 2, 2021|||3|}}<br>
 
* Indolent and Reactive Mimics of Lymphoma - Dr. Ferry
 
* Indolent and Reactive Mimics of Lymphoma - Dr. Ferry
Line 41: Line 42:
 
* 2021 WHO Classification of CSN - Dr. Louis
 
* 2021 WHO Classification of CSN - Dr. Louis
 
* Premalignanv Malignant Epithelial Lesions - Dr. Watkins
 
* Premalignanv Malignant Epithelial Lesions - Dr. Watkins
 +
<br>
 
{{ColorText|Wednesday, November 3, 2021|||3|}}<br>
 
{{ColorText|Wednesday, November 3, 2021|||3|}}<br>
 
* Challenges in Salivary Gland Pathology - Dr. Faquin
 
* Challenges in Salivary Gland Pathology - Dr. Faquin
Line 50: Line 52:
 
* Fibroepithelial Neoplasms - Dr. Lerwill
 
* Fibroepithelial Neoplasms - Dr. Lerwill
 
* Melanocytic Neoplasms - Dr. Foreman
 
* Melanocytic Neoplasms - Dr. Foreman
 +
<br>
 
{{ColorText|Thursday, November 4, 2021|||3|}}<br>
 
{{ColorText|Thursday, November 4, 2021|||3|}}<br>
 
* BD Challenges & Controversies - Dr. Misdraji
 
* BD Challenges & Controversies - Dr. Misdraji
Line 56: Line 59:
 
* EBC-associated LPD - Dr. Sohani
 
* EBC-associated LPD - Dr. Sohani
 
* Pleural Peritoneal Meso - Dr. Hung
 
* Pleural Peritoneal Meso - Dr. Hung
 +
<br>
 
{{ColorText|Friday, November 5, 2021|||3|}}<br>
 
{{ColorText|Friday, November 5, 2021|||3|}}<br>
 
* Mesenchymal tumors - Dr. Oliva
 
* Mesenchymal tumors - Dr. Oliva
Line 64: Line 68:
 
* Gastritis Beyond H - Dr. Zukerberg
 
* Gastritis Beyond H - Dr. Zukerberg
 
* Germ Cell Tumors of the Ovary - Dr. Young
 
* Germ Cell Tumors of the Ovary - Dr. Young
{{ColorText|Slideshow Presentations||#30705d|5|}}<br><br>
 
 
<headertabs/>
 
<headertabs/>

Revision as of 09:30, October 25, 2021

Case Presentations

All

Monday, November 1, 2021


Tuesday, November 2, 2021


Wednesday, November 3, 2021


Thursday, November 4, 2021


Friday, November 5, 2021

  • 12:30 pm – 1:15 pm: Gastrointestinal Pathology, Stuti G. Shroff
  • 1:15 pm – 2:00 pm: Genitourinary Pathology, Chin-Lee Wu


Monday, November 1, 2021


Tuesday, November 2, 2021

  • Indolent and Reactive Mimics of Lymphoma - Dr. Ferry
  • Mucinous Tumors of the Ovary - Dr. Young
  • Critical Values in Perinatal Pathology - Dr. Roberts
  • Diffuse Large B-Cell Lymphoma, An Update - Dr. Sohani
  • Eight Common Reasons - Dr. Roberts
  • Testis - Dr. Cornjeo
  • Selected Benign Bladder Lesions - Dr. Young
  • 2021 WHO Classification of CSN - Dr. Louis
  • Premalignanv Malignant Epithelial Lesions - Dr. Watkins


Wednesday, November 3, 2021

  • Challenges in Salivary Gland Pathology - Dr. Faquin
  • Gastrointestinal Polyps - Dr. Zukerberg
  • 2021 WHO Class of Lung Tumors - Dr. Mino-Kenudson
  • Diagnosis of Interstitial Lung Disease - Dr. Hairi
  • Vasculitis - Dr. Stone
  • Nipple Lesions - Dr. Ly
  • Fibroepithelial Neoplasms - Dr. Lerwill
  • Melanocytic Neoplasms - Dr. Foreman


Thursday, November 4, 2021

  • BD Challenges & Controversies - Dr. Misdraji
  • Papillary Lesions - Dr. Lerwill
  • Endocervical - Dr. Oliva
  • EBC-associated LPD - Dr. Sohani
  • Pleural Peritoneal Meso - Dr. Hung


Friday, November 5, 2021

  • Mesenchymal tumors - Dr. Oliva
  • IBD Challenges & Controversies - Dr. Misdraji
  • IBD Challenges & Controversies - Dr. Deshpande
  • Prostate Cancer Pathology - Dr. Wu
  • Approach to Mistakes - Dr. Heher
  • Gastritis Beyond H - Dr. Zukerberg
  • Germ Cell Tumors of the Ovary - Dr. Young